dow-jones
Objective Price Target Cut 51% to A$10.80/Share by Shaw & Partners
Objective Price Target Cut 51% to A$10.80/Share by Shaw & Partners
dow-jones
Golden Horse Minerals Price Target Cut 17% to A$1.25/Share by Shaw & Partners
Golden Horse Minerals Price Target Cut 17% to A$1.25/Share by Shaw & Partners
dow-jones
Regal Partners Price Target Raised 2.1% to A$4.80/Share by Bell Potter
Regal Partners Price Target Raised 2.1% to A$4.80/Share by Bell Potter
dow-jones
Echo IQ Downgraded to Speculative Hold from Buy by Bell Potter
Echo IQ Downgraded to Speculative Hold from Buy by Bell Potter
dow-jones
Echo IQ Price Target Raised 6.1% to A$1.75/Share by Bell Potter
Echo IQ Price Target Raised 6.1% to A$1.75/Share by Bell Potter
dow-jones
Life360 Price Target Raised 6.1% to A$35.00/Share by Bell Potter
Life360 Price Target Raised 6.1% to A$35.00/Share by Bell Potter
dow-jones
AMP Has Scope for Additional Capital Management — Market Talk
Wealth manager AMP can pursue more capital management, UBS says. It assumes further returns of A$150 million in 2H26. AMP had A$287 million of surplus CET1 capital--essentially a buffer against financial shocks--and that will build as profit grows. UBS also points to AMP's seemingly low dividend po…
dow-jones
Intelligent Monitoring Group Price Target Raised 19% to A$1.25/Share by Canaccord Genuity
Intelligent Monitoring Group Price Target Raised 19% to A$1.25/Share by Canaccord Genuity
dow-jones
Mayne Pharma Price Target Cut 37% to A$3.83/Share by Canaccord Genuity
Mayne Pharma Price Target Cut 37% to A$3.83/Share by Canaccord Genuity
dow-jones
Celltrion 2Q Op Pft Estimate Beat FactSet-Compiled Market Consensus
Celltrion 2Q Op Pft Estimate Beat FactSet-Compiled Market Consensus
dow-jones
Mayne Pharma Moved to Speculative Buy from Buy by Canaccord Genuity
Mayne Pharma Moved to Speculative Buy from Buy by Canaccord Genuity
dow-jones
Celltrion Sees 2Q Op Pft KRW430.00B, Up 77% on Year >068270.SE
Celltrion Sees 2Q Op Pft KRW430.00B, Up 77% on Year >068270.SE
dow-jones
Celltrion Sees 2Q Rev KRW1.300T, Up 35% on Year >068270.SE
Celltrion Sees 2Q Rev KRW1.300T, Up 35% on Year >068270.SE
dow-jones
Objective Price Target Cut 25% to A$16.00/Share by Morgan Stanley
Objective Price Target Cut 25% to A$16.00/Share by Morgan Stanley
dow-jones
Australia Stock Futures Point to Opening Rise — Market Talk
Australian stock futures are pointing to an opening rise ahead of the week's final trading session. ASX futures are up by about 0.6% before Friday's open, suggesting that the S&P/ASX 200 could avoid a second straight weekly decline. The benchmark index is down by almost 0.5% so far this week after…
dow-jones
Samsung's Share Price Pullback May Be Technical Correction — Market Talk
Samsung Electronics' recent share price pullback may reflect a technical correction despite market concerns about excess artificial-intelligence computing capacity, Citigroup's Peter Lee says. The analyst expects the South Korean tech giant's 2Q operating profit to reach 84 trillion won, supported…
Sunoco, Energy Transfer, USA Compression Partners to Redomicile in Texas
By Elias SchisgallA group of major energy companies is heading to the Lone Star State.Energy Transfer, Sunoco, SunocoCorp, and USA Compression Partners plan to move their businesses to Texas from Delaware, the companies jointly announced Thursday.Their redomiciliations would be legally effective on…
dow-jones
Hub24 Price Target Cut 5.5% to A$86.00/Share by UBS
Hub24 Price Target Cut 5.5% to A$86.00/Share by UBS
dow-jones
AMP Price Target Raised 16% to A$1.91/Share by UBS
AMP Price Target Raised 16% to A$1.91/Share by UBS
dow-jones
Netwealth Price Target Cut 9.4% to A$24.45/Share by UBS
Netwealth Price Target Cut 9.4% to A$24.45/Share by UBS